Alliancebernstein L.P. boosted its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 273.8% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 1,109,045 shares of the biotechnology company's stock after purchasing an additional 812,337 shares during the period. Alliancebernstein L.P. owned approximately 1.45% of Axon Enterprise worth $659,128,000 at the end of the most recent quarter.
A number of other institutional investors have also modified their holdings of AXON. New Wave Wealth Advisors LLC acquired a new position in Axon Enterprise in the fourth quarter valued at approximately $40,000. Y.D. More Investments Ltd acquired a new position in shares of Axon Enterprise in the 4th quarter valued at $45,000. Prestige Wealth Management Group LLC boosted its holdings in Axon Enterprise by 115.8% during the third quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company's stock worth $33,000 after buying an additional 44 shares in the last quarter. Stonebridge Financial Group LLC purchased a new position in Axon Enterprise in the fourth quarter valued at $53,000. Finally, GPS Wealth Strategies Group LLC raised its position in shares of Axon Enterprise by 74.1% in the fourth quarter. GPS Wealth Strategies Group LLC now owns 94 shares of the biotechnology company's stock worth $56,000 after acquiring an additional 40 shares during the period. Hedge funds and other institutional investors own 79.08% of the company's stock.
Axon Enterprise Trading Down 7.8 %
Shares of NASDAQ AXON traded down $42.30 during midday trading on Friday, hitting $497.39. The stock had a trading volume of 394,468 shares, compared to its average volume of 803,160. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a 1-year low of $273.52 and a 1-year high of $715.99. The company has a market capitalization of $38.11 billion, a price-to-earnings ratio of 128.52, a PEG ratio of 5.17 and a beta of 1.13. The company has a fifty day moving average price of $584.52 and a 200 day moving average price of $552.70.
Wall Street Analyst Weigh In
AXON has been the topic of several recent analyst reports. Northcoast Research downgraded shares of Axon Enterprise from a "buy" rating to a "neutral" rating in a report on Wednesday, February 19th. Robert W. Baird increased their price objective on Axon Enterprise from $600.00 to $800.00 and gave the company an "outperform" rating in a research note on Friday, December 6th. The Goldman Sachs Group lifted their price objective on shares of Axon Enterprise from $500.00 to $700.00 and gave the stock a "buy" rating in a research report on Monday, January 27th. Needham & Company LLC restated a "buy" rating and issued a $600.00 price target on shares of Axon Enterprise in a research note on Wednesday, February 26th. Finally, Barclays reissued a "hold" rating on shares of Axon Enterprise in a research report on Monday, March 10th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and eleven have assigned a buy rating to the stock. Based on data from MarketBeat, Axon Enterprise has an average rating of "Moderate Buy" and an average target price of $604.67.
Check Out Our Latest Research Report on AXON
Insider Activity at Axon Enterprise
In other Axon Enterprise news, Director Jeri Williams sold 307 shares of the stock in a transaction on Monday, March 17th. The shares were sold at an average price of $552.72, for a total transaction of $169,685.04. Following the sale, the director now directly owns 1,627 shares of the company's stock, valued at approximately $899,275.44. This represents a 15.87 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 6.10% of the company's stock.
About Axon Enterprise
(
Free Report)
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Featured Articles

Before you consider Axon Enterprise, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.
While Axon Enterprise currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.